Who
Donald A. Zakrowski
SVP, Finance, & CAO
Company insider
Files Form 4 as: SVP, Finance, & CAO, Eli Lilly and.
In numbers
- Trades disclosed
- 72
- Buys
- 0
- Sells
- 32
- Bought
- $0
- Sold
- $14.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Dec 2012
- Last trade
- 10 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Nov 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 11 Aug 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $2.4M2,000 at $1,185.01 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $2.4M2,000 at $1,185.01 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —184 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $85K81.553 at $1,040.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —184 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —184 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —184 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $85K81.55 at $1,040.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $610K583.784 at $1,044.67 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —199.472 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —199.47 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $610K583.78 at $1,044.67 | filing |
| 13 Nov 2025filed 13 Nov 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $1.0M1,000 at $1,010.50 | filing |
| 28 Aug 2025filed 28 Aug 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $735K1,000 at $734.93 | filing |
| 27 May 2025filed 27 May 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $716K1,000 at $716.41 | filing |
| 13 Mar 2025filed 13 Mar 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $818K1,000 at $818.24 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —216.39 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1.2M1,359.66 at $868.88 | filing |
| 8 Nov 2024filed 8 Nov 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $723K900 at $803.38 | filing |
| 26 Aug 2024filed 26 Aug 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Sold | $713K750 at $950.00 | filing |
News
Eli Lilly and Company (NYSE:LLY) EVP Anat Hakim Sells 5,000 Shares of Company StockLLY · themarketsdaily.com · 3 Nov 2026450 Eli Lilly and Company $LLY Shares Purchased by Vigilare Wealth ManagementLLY · dailypolitical.com · 3 Nov 2026Trek Financial LLC Buys 380 Shares of Eli Lilly and Company $LLYLLY · dailypolitical.com · 3 Nov 2026
0 headlines in the last 90 days name Donald A. Zakrowski; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.